Form 4: Pfizer Director Desmond-Hellmann Acquires Phantom Stock Units as Deferred Compensation

Director Susan Desmond-Hellmann acquired 8,999 phantom stock units of Pfizer as part of a deferred compensation plan.

Summary

• On April 24, 2025, Susan Desmond-Hellmann, a director of Pfizer Inc., acquired 8,999 phantom stock units.
• These units were granted under Pfizer's Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
• Each unit represents one phantom share of Pfizer common stock.
• The price of the underlying common stock at the time of the transaction was $22.78.
• Following the transaction, Desmond-Hellmann beneficially owns 37,355.127 phantom stock units.
• The phantom stock units represent deferred director's compensation that will be settled in cash or common stock at the director's election following retirement from the Board of Directors.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment as it aligns director interests with the company's long-term performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of Pfizer.
• Deferred compensation plans can be tax-efficient for directors.

Future Outlook

The document does not contain specific forward-looking statements regarding Pfizer's future performance.

Industry Context

Deferred compensation plans are a common practice for compensating non-employee directors in publicly traded companies, aligning their interests with shareholder value.

Comparison to Industry Standards

• Many large pharmaceutical companies, such as Johnson & Johnson and Merck, utilize deferred compensation plans for their non-employee directors.
• These plans often involve the grant of stock options, restricted stock units, or phantom stock units, similar to the arrangement described in the filing.
• The specific terms and conditions of these plans can vary, but the overall objective is to incentivize directors to focus on long-term value creation.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively impact shareholders by aligning the director's interests with the company's long-term success.
• The plan provides a form of compensation for the director.

Key Dates

Keywords

Form 4, Pfizer, Director, Desmond-Hellmann, Phantom Stock Units, Deferred Compensation, Beneficial Ownership, PFE